Intimation for Closure of Trading Window

BAFNA PHARMACEUTICALS LIMITED REGD. OFFICE: “BAFNA TOWERS”, NO.299, THAMBU CHETTY STREET, CHENNAI – 600001, TAMIL NADU, INDIA PHONE: 044-25267517/25270992/42677555, FAX: 91-44-25231264, Email: info@bafnapharma.com, Website: www.bafnapharma.com CIN: L24294TN1995PLCO30698 Date: September 26, 2026 BSE Limited, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Mumbai - 400001. Bandra East, Mumbai – 400051. Scrip Code: 532989 Scrip Code: BAFNAPH Dear Sir/Madam, Subject: Closure of Trading Window for the Quarter ended September 30, 2026 Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, read with Company’s Code of Conduct for Prevention of Insider Trading, the “Trading Window” for dealing in the Company’s Securities by the Designated Persons of the Company and their immediate relatives, will remain closed from October 01, 2026 till 48 Hours after the declaration of Un-audited Financial Results for the Quarter ending September 30, 2026 (Both Days Inclusive). Accordingly, all the Designated Persons of the Company and their immediate relatives have been intimated not to trade in the Company’s securities during the aforesaid period of closure of Trading Window. Kindly take the above information on record. Thanking You. For BAFNA PHARMACEUTICALS LIMITED Mohanachandran A Company Secretary & Compliance Officer Factory: No.147, Madhavaram Redhills High Road, Grantlyon Village, Vadakarai Post, Chennai-600 052, TN, India Phone: 9445149001 Email: factory1@bafnapharma.com